myocardial infarction (STEMI) treated with PCI. 2 Percutaneus coronary intervention (PCI) is a preferred method of reperfusion for ST-segment Elevation Myocardial Infarction (STEMI). 3 The aim of Reperfusion therapy in acute myocardial infarction (AMI) is early and sustained reperfusion of the myocardium at risk. Reperfusion therapy is considered to be angiographically successful when a good TIMI (thrombolysis in myocardial infarction) flow is achieved in the infarct-related coronary artery. 4, 5 Improved epicardial flow assessed by TIMI flow grades (TFG) has been related to reduced mortality after coronary revascularization. 4, 6, 7, 8 However, even when a good TIMI flow is achieved, some patients have less than optimal reperfusion at the tissue level, and myocardial reperfusion is not always achieved in patients with a good TIMI flow of epicardial coronary artery. Several mechanisms have been suggested to be involved such as no reflow and distal embolization. 9, 10 TIMI myocardial perfusion grade (TMPG) is an angiographic measure of myocardial perfusion at capillary level. 9 TMPG has been found to be useful in both pharmacological and catheter based reperfusion after AMI and is suggested as a useful indicator of successful myocardial reperfusion. 10 Patients with both normal epicardial flow and myocardial perfusion have been shown to have a very low mortality rate of 0.73%. 11 Thus, the TMPG adds additional prognostic information to the conventional epicardial TFG. 11 Incorporation of these two variables envisaging a combined index of epicardial and myocardial microvascular blood flow has been suggested as the Angiographic Perfusion Score (APS). 12 APS is a simple, angiographic metric that takes into account indices of epicardial and myocardial perfusion, both before and after PCI, to arrive at a single perfusion grade. The APS is the sum of the TFG (0-3) added to the TMPG (0-3) before and after PCI, therefore, a total grade of 0 to 12 is possible. Failed perfusion was defined as an APS of 0-3, partial perfusion as an APS of 4-9, and full perfusion as an APS of 10-12. Among STEMI patients with larger infarct sizes, the association of APS with the incidence of death or MI has been found to be statistically significant with an APS score of (0-9). 12 Evidence thus favors that the APS, which combines grades of epicardial and tissue level perfusion before and after PCI may be closely associated with infarct size, and may prove valuable in clinical risk stratification. The aim of this study is to assess short term clinical outcome after PCI in a patient of ST-segment elevation myocardial infarction (STEMI) without thrombolytic pretreatment.
Materials And Methods

Place of study:
Cross-sectional observational study was done in the Department of Cardiology, University Cardiac Center, Bangabandhu Sheikh Mujib Medical University, Shahbag, Dhaka from July 2017 to June 2018.
Study population:
Adult patients present with ST-segment elevation myocardial infarction (STEMI) without thrombolytic pretreatment who are undergoing Percutaneous Coronary Intervention (PCI).
The eligibility criteria was as follows:
Inclusion Criteria: 1) STEMI patients undergoing Primary PCI.
2) STEMI patient presenting after 12 hours with cardiogenic shock.
3) STEMIpatient with ongoing symptom presenting within 72 hours.
Exclusion Criteria 1) STEMI patients treated with thrombolytic.
2) STEMI presented after 72 hours.
3) Failed PCI in STEMI patients.
4) PCI in NSTEMI, UA patients
A data sheet was used for each patient. Data were analyzed by SPSS 20.0 software
Results:
Figure no. 01 reveals that majority (34.1%) of the patients belonged to age group of 51-60 years, 32.2% of them belonged to age group of 41-50 years and only 13.9% belonged to the age group of d"40 years. The mean age and SD was found 52.83 ±10.147 years.
The following pie chart reveals that among all, 88.8% of the patients were male and only 11.2% of the patients were female.
Interpretation : Most of the patient were male which correlate with the trend of coronary artery disease which is a male predominant disease. Table 3 disclose that MACE distribution of the study patients, It was observed that only 7.8% of the patients had MACE, whereas 92.2% of the patients had no MACE. Table 4 finds that Chi square test between APS score with MACE distribution of the study patients. It was observed that the frequency of MACE in the patients with full perfusion was 0.0%, 9.3% of partial perfusion and 44.4% among failed perfusion group. The difference were statistically highly significant (p<0.05) among three groups. There were no differences in the baseline characteristics of those who had full, partial or failed perfusion.
Conclusion:
The APS combines grades of epicardial and tissue level perfusion before and after PCI to arrive at a single angiographic predictor of MACE. No patients with full angiographic perfusion died but partial or full angiographic perfusion group of patients are associated with MACE. To optimize outcomes, both epicardial and myocardial perfusion must be restored to normal. TFG which is the favored method of predicting outcomes has the ambiguity of using a single parameter taken at one point in time, and is low on sensitivity to identify patients with good prognosis after PCI. This can be overcome by the simple scoring system of APS which combines TMPG with TFG before and after PCI andtakes care of the minor differences arising out of operator related interpretation of the angiographic parameters. APS is a better discriminator of 30 day MACE than TMPG or TFG alonetaken only after PCI. We conclude that APS is a better predictor of MACE to take care of patient more accurately.
